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Abstract 23 
Daily activities often require sudden cancellation of pre-planned movement, termed 24 
response inhibition. When only a subcomponent of a whole response must be suppressed 25 
(required herein on Partial trials), the ensuing component is markedly delayed. The neural 26 
mechanisms underlying partial response inhibition remain unclear. We hypothesized that 27 
Partial trials would be associated with non-selective corticomotor suppression and that 28 
GABAB-receptor mediated inhibition within primary motor cortex might be responsible for 29 
the non-selective corticomotor suppression contributing to Partial trial response delays. 30 
Sixteen right-handed participants performed a bimanual anticipatory response inhibition task 31 
while single and paired-pulse transcranial magnetic stimulation was delivered to elicit motor 32 
evoked potentials in the left first dorsal interosseous muscle. Lift times, amplitude of motor 33 
evoked potentials and long-interval intracortical inhibition were examined across the different 34 
trial types (Go, Stop-Left, Stop-Right, Stop-Both). Go trials produced a tight distribution of 35 
lift times around the target, whereas those during Partial trials (Stop-Left and Stop-Right) 36 
were substantially delayed. The modulation of motor evoked potential amplitude during Stop-37 
Right trials reflected anticipation, suppression and subsequent re-initiation of movement. 38 
Importantly, suppression was present across all Stop trial types, indicative of a “default” non-39 
selective inhibitory process. Compared with blocks containing only Go trials, inhibition 40 
increased when Stop trials were introduced but did not differ between trial types. The amount 41 
of inhibition was positively correlated with lift times during Stop-Right trials. Tonic levels of 42 
inhibition appear to be proactively modulated by task context and influence the speed at 43 
which unimanual responses occur after a non-selective “brake” is applied.  44 
 45 
 46 
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New & Noteworthy 47 
The ability to cancel a pre-planned movement, termed response inhibition, is essential for 48 
adaptable motor control. Participants performed a bimanual anticipatory response inhibition 49 
task while single and paired-pulse transcranial magnetic stimulation was delivered. The 50 
modulation of motor evoked potential amplitude during partial response trials reflected 51 
anticipation, suppression and subsequent re-initiation of movement. Importantly, suppression 52 
was present across all stop trial types, indicative of a "default" non-selective inhibitory 53 
process. 54 
  55 
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Introduction 56 
The ability to cancel a pre-planned movement, termed response inhibition, is essential 57 
for adaptable motor control. Response inhibition relies upon a cortico-subcortical network 58 
(Aron and Poldrack 2006; Chambers et al. 2006; Coxon et al. 2009; Coxon et al. 2012; 59 
Zandbelt et al. 2013) that inhibits corticospinal neurons (CSNs) within the primary motor 60 
cortex (M1) in order to suppress descending motor output (Stinear et al., 2009). It is known 61 
that gamma-aminobutyric acid (GABA) mediated interneurons within M1 exert powerful 62 
inhibitory effects on CSNs (Jones 1993; Keller 1993). However, the role of GABA-ergic 63 
inhibition during response inhibition is not fully understood. 64 
Response inhibition can be proactive when stopping demands are anticipated, or 65 
reactive when stop signals are presented unexpectedly (Aron and Verbruggen 2008). 66 
Transcranial magnetic stimulation (TMS) has been used to assess the temporal modulation of 67 
corticomotor excitability (CME) during both types of response inhibition. Proactive stopping 68 
is suggested to recruit the indirect basal ganglia pathway to selectively decrease CME for 69 
only the movement cued to stop (Aron and Verbruggen 2008; Cai et al. 2011; Majid et al. 70 
2013). A topic of current debate is whether reactive stopping can be achieved selectively (Xu 71 
et al. 2014),  given that several lines of evidence indicate a transient process in which 72 
stopping response preparation suppresses movement non-selectively. For example, when 73 
successful stopping can be achieved by inhibiting all movement, CME is reduced in 74 
response-irrelevant muscles (Badry et al. 2009; Cai et al. 2012; Coxon et al. 2006; 75 
Greenhouse et al. 2012). When only a subcomponent of a prepared response is required to 76 
stop (Partial trials), the remaining response is delayed (Coxon et al. 2007; 2009; Coxon et al. 77 
2012; MacDonald et al. 2014; MacDonald et al. 2012). Interestingly there is also a 78 
concomitant reduction in CME for the responding left hand on trials when only the right hand 79 
is cued to stop (MacDonald et al. 2014), indicative of a non-selective inhibitory process that 80 
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cancels all prepared effectors. The subsequent delay may arise as a consequence of having to 81 
initiate a new response. While these studies suggest reactive response inhibition is non-82 
selective, the primary suppressive mechanism remains unclear. 83 
Intracortical networks within M1 are the final cortical modulators of motor output. 84 
Paired-pulse TMS can be used to investigate GABA-ergic inhibition within M1 and identify 85 
the contribution of distinct intracortical networks to motor performance (Reis et al. 2008). 86 
GABAA-receptor mediated short-interval intracortical inhibition (SICI), assessed using a 87 
subthreshold conditioning stimulus followed 1-6 ms later by a suprathreshold test stimulus 88 
(Kujirai et al. 1993), is involved with movement initiation and prevention. SICI is selectively 89 
reduced during movement initiation (Reynolds and Ashby 1999; Stinear and Byblow 2003; 90 
Zoghi et al. 2003). While GABAA-mediated networks within M1 are essential for specific, 91 
point-to-point control over motor representations, SICI is non-selectively increased following 92 
stop signal presentation during unimanual response inhibition (Coxon et al. 2006). However, 93 
MacDonald et al. (2014) could not temporally reconcile non-selective CME suppression with 94 
an increase in SICI during partial response inhibition, making it an unlikely candidate 95 
mechanism underlying the behavioral and neurophysiological findings observed when only a 96 
subcomponent of a prepared response must be terminated. 97 
Within M1, GABAB-receptor mediated inhibition can be assessed as long-interval 98 
intracortical inhibition (LICI) using suprathreshold conditioning and test stimuli separated by 99 
50-200 ms (Valls-Solé et al. 1992; Wassermann et al. 1996). LICI engages pre-synaptic 100 
receptors (Bettler et al. 2004), typically associated with tonic inhibitory effects. Interestingly, 101 
one study reported decreased LICI in a Go/No-Go task (Sohn et al. 2002) but did not assess 102 
LICI using an optimal interstimulus interval (Sanger et al. 2001) or use conditioning stimulus 103 
intensities that allowed increases in LICI to be observed. Therefore, the role of LICI in 104 
reactive response inhibition is yet to be established.  105 
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There were three aims of the present study. First, we wanted to confirm and extend on 106 
the finding that Partial trials are associated with non-selective CME suppression as 107 
demonstrated by MacDonald et al. (2014). We hypothesized that CME, as evident by MEP 108 
amplitude, would be reduced during Partial trials, supporting a model of non-selective 109 
suppression (MacDonald et al. 2014), and that CME suppression would occur at equivalent 110 
time points whether one or both sides were cued to stop. Second, we hypothesized that LICI 111 
would be up-regulated during response inhibition trials compared with Go trials irrespective 112 
of Stop trial type i.e., indicative of a non-selective inhibitory mechanism. Finally, we wanted 113 
to examine CME and LICI at the onset of trials to determine if either could explain why lift 114 
times are influenced by previous trial type (Coxon et al. 2007; MacDonald et al. 2012).  115 
Methods 116 
Participants  117 
Sixteen participants without neurological impairment participated in the experiment (mean 118 
age 24 y, range 18-49 y, 14 male). Thirteen of these completed the LICI protocol (mean age 119 
25 y, range 18-49 y, 11 male). All were right handed (laterality quotient mean 0.92, range 120 
0.71-1) as determined using a four-item version of the Edinburgh handedness inventory 121 
(Veale 2014). Written consent was obtained before participation and the study was approved 122 
by the University of Auckland Human Participants Ethics Committee.  123 
Response inhibition task 124 
The experiment utilized a bimanual anticipatory response inhibition task (Coxon et al. 125 
2007; 2009; MacDonald et al. 2014; MacDonald et al. 2012). Participants were seated with 126 
forearms resting on a table positioned midway between pronation and supination. This 127 
allowed the distal and medial aspect of each index finger to occupy a mechanical switch 128 
positioned 55 cm away from the computer monitor. The display consisted of two indicators 129 
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(vertical rectangles) each 16 cm in length and 1.5 cm in width (Figure 1A). Control of the left 130 
or right indicator was via the corresponding left or right switch. Switch “up/down” state was 131 
precisely recorded through an Arduino and synchronized to the display through an analog-132 
digital USB interface (NI-DAQmx 9.7; National Instruments). Customized software written 133 
in MATLAB (R2011a, version 7.12; The MathWorks) generated the trial order, recorded trial 134 
data and controlled the visual output during the task. 135 
Participants were instructed to let the weight of their fingers passively depress the 136 
switches. Switch height was adjusted to eliminate any positional related muscle activity. 137 
Depression of both switches initiated the trial after a 400-900 ms variable delay. If depression 138 
continued, both indicators would ascend vertically at a constant velocity reaching a horizontal 139 
line after 800 ms and the top of the display after 1000 ms. Participants were informed that 140 
releasing the switch (index finger abduction) would stop the corresponding indicator. Go 141 
trials (Go-Left Go-Right; GG) required participants to stop both indicators at the target by 142 
releasing both switches (Figure 1B). Stop trials were cued by one or both indicators stopping 143 
before the target, requiring participants to inhibit the response of one or both hands (Figures 144 
1C and D). In the protocols a 2:1 ratio of Go to Stop trials existed, establishing Go trials as 145 
the default response. When both hands were required to stop (Stop-Both i.e. Stop-Left Stop-146 
Right; SS), both indicators stopped 600 ms into the trial. On Partial trials only one hand was 147 
required to stop (Go-Left Stop-Right; GS, or Stop-Left Go-Right; SG). On Partial trials a 148 
single indicator stopped 550 ms into the trial while the other continued to ascend. The time 149 
the indicator stopped on Stop trials (550 & 600 ms) did not change. This enabled constant 150 
TMS times relative to both the stopping of the indicator and the start of the trial. Feedback 151 
was visually displayed during each inter-trial interval. 152 
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Electromyography 153 
MEP amplitude was recorded using electromyography (EMG) over the left first dorsal 154 
interosseous (FDI) muscle as the non-dominant hand is more strongly affected than the 155 
dominant hand by the processes required to successfully cancel a subset of a movement 156 
(MacDonald et al. 2012). A belly-tendon electrode montage was used with a ground electrode 157 
on the posterior hand surface. EMG activity was recorded using a National Instruments A/D 158 
acquisition system, displayed using custom LabVIEW software, and stored to disk for offline 159 
analysis. Electrical activity was amplified (Grass P511AC), band-pass filtered (10-1000 Hz) 160 
and sampled at 2 kHz.  161 
Transcranial magnetic stimulation 162 
To examine CME during successful Stop and Go trials single-pulse TMS was delivered 163 
using a single Magstim 200 stimulator (Magstim, Dyfed, United Kingdom). A figure-of-eight 164 
coil (70 mm diameter) was held tangentially over the right M1 of the participant. The optimal 165 
coil position for eliciting MEPs in the left FDI was determined using a slightly suprathreshold 166 
intensity and marked on the scalp. The handle was posteriorly positioned and the coil 167 
orientated at a 45°angle to the midline, inducing a posterior to anterior directed current 168 
(Brasil-Neto et al. 1992). To examine LICI we delivered paired-pulse TMS from two 169 
Magstim 200 units connected via a Bistim unit (Magstim, Dyfed, United Kingdom). The 170 
CME protocol always preceded the LICI protocol.  171 
Protocol 172 
To examine CME, Task Motor Threshold (TMT) was determined while the participant 173 
rested their index fingers on the switches. TMT was determined as the minimum stimulus 174 
intensity required to elicit a MEP of at least 50 µV in the FDI in 4 out of 8 consecutive trials. 175 
Stimulus intensity was adjusted in 1-2 % increments from TMT to produce an average MEP 176 
amplitude of 0.1-0.2 mV at 200 ms before the target while not disrupting task performance. 177 
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This intensity was then used for all remaining stimulated trials. Participants completed an 178 
unstimulated practice block of 36 trials containing pseudo-randomized Stop trials. 179 
The task in the CME protocol consisted of 432 trials split into 12 pseudo-randomized 180 
blocks of 36 with 288 Go and 144 Stop trials. There were 98 Go trials where TMS was 181 
delivered at either 250, 225, 200, 175, 150, 125 or 100 ms before the target to obtain 14 182 
stimuli at each time point. All Stop trials were stimulated and distributed as 84 GS, 30 SG 183 
and 30 SS because GS trials were of primary interest. For GS trials, 14 stimuli were delivered 184 
150, 125, 100, 75, 50 and 25 ms before the target. Timing was delayed by 100 ms relative to 185 
Go trials because of the expected ~75 - 100 ms delay in the responding hand (Coxon et al. 186 
2007; 2009; Coxon et al. 2012; MacDonald et al. 2014; MacDonald et al. 2012). For SG and 187 
SS trials, 15 stimuli were delivered 175 and 200 ms after the stop signal. 188 
To examine LICI, paired-pulse TMS was delivered at an ISI of 100 ms (Sanger et al. 189 
2001). Stimulation intensity was adjusted to elicit a cortical silent period (CSP) duration of 190 
175 ms while left FDI was activated at ~10% of maximum voluntary contraction. This 191 
intensity was used in LICI for both the conditioning stimulus (CS) and the test stimulus (TS). 192 
CS and TS were then adjusted to produce approximately 50-85% inhibition of the MEP 193 
amplitude (%INH). This intensity was used for all following trials.  194 
During the LICI protocol, participants performed a Go Only block consisting of 30 195 
Go trials. %INH was measured at the start of each trial (0 ms). Each participant then 196 
performed the task, which consisted of 360 trials split into 10 blocks of 36 trials. Of these, 197 
240 (67%) were Go trials and 120 (33%) were Stop trials. Stop trial types (GS, SG and SS) 198 
were equally represented, each condition consisting of 40 trials. The %INH obtained at 0 ms 199 
provided information for the previous and upcoming trial. All trials following Stop trials and 200 
185 trials following Go trials were stimulated.  201 
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Dependent measures  202 
Peak-to-peak MEP amplitude was calculated from EMG 10 to 50 ms after the 203 
stimulus. MEPs were excluded when root mean square (rms) EMG was > 10 µV in the 50 ms 204 
preceding stimulation. Also, EMG traces were excluded if any activity was present between 205 
the stimulus and MEP evident from visual inspection. Average MEP amplitude was 206 
calculated following trimming of the upper and lower 10 % (if > 8 MEPs were present for 207 
that time point) or ± 1.5 standard deviations (if 4 – 8 MEPs were present for that time point). 208 
To reduce inter-subject variability MEP amplitude was normalised across Trial Types and 209 
Stimulations Times such that the condition with the largest mean MEP amplitude was 210 
reassigned the value 1, and all other conditions scaled accordingly for the participant. For the 211 
LICI protocol, mean stimulated and unstimulated left hand LTs were calculated from Go 212 
trials after Go trials. MEP amplitude was calculated for each stimulated trial in the left hand 213 
for both CS and TS. The primary dependent measure was %INH, which was calculated as 214 
%INH = 100 – (TS MEP amplitude/ CS MEP amplitude) ×100, where TS and CS MEP 215 
amplitude are the mean values for each condition from each participant. ∆%INH and ∆CS 216 
MEP amplitude was calculated for Partial trials followed and preceded by Go trials. ∆ = 217 
[(subsequent Go trial – Partial trial)/ Partial trial] × 100.  218 
To assess behaviour, lift times (LTs) were recorded and are reported relative to the 219 
target. Mean LTs from Go and successful Partial trials were calculated after the removal of 220 
outliers (± 3 SD; 1% removed for Go and Partial trials in CME protocol, 2% removed for Go 221 
and Partial trials in LICI protocol). In the LICI protocol only, lift time asynchronies (LTAs) 222 
were calculated from LTs in Go trials following Go and successful Stop trials (LTA = [Left 223 
hand LT] – [Right hand LT]). For Stop trials, stop signal reaction time (SSRT) and 224 
percentage of successful trials were determined. SSRT was calculated using the integration 225 
method (Logan and Cowan 1984; Verbruggen et al. 2013).  226 
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Statistical analyses  227 
Repeated measures Analysis of Variance (RM ANOVA) were used to test our 228 
hypotheses. To test the first hypothesis, normalized MEP amplitude was first compared in an 229 
omnibus RM ANOVA with a 2 Trial Type (GG, GS) × 6 Stimulation Time (-225, -200, -175, 230 
-150, -125 and -100 ms relative to expected LT i.e. 0 ms on GG, 75 ms on GS) design. To 231 
determine if the hypothesised pattern of facilitation, suppression and facilitation on Partial 232 
Trials was present, one-way RM ANOVAs with the factor Stimulation Time (6 levels) were 233 
run separately on GS and GG trials.  Additionally, MEP amplitude for Stop trials was 234 
analyzed with a 3 Trial Type (GS, SG, SS) x 2 Stimulation Time (175, 200 ms post stop 235 
signal) RM ANOVA. Participants with fewer than 4 MEPs for more than one stimulation 236 
time across trial types were excluded from analysis. For all other analyses in the CME 237 
protocol, missing data points were replaced with the average of the row and column mean. To 238 
determine task compliance behavioral data were analyzed as follows. LTs on Go and Partial 239 
trials were analyzed with a two-way RM ANOVA with factors Trial Type (Go, Partial) and 240 
Hand (Left, Right). LTAs from Go trials in the LICI protocol were analyzed using a one-way 241 
RM ANOVA with Preceding Trial Type (GG, GS, SG, SS). LTs that contributed to LTAs 242 
were analyzed in a two-way RM ANOVA with factors Preceding Trial Type (GG, GS, SG, 243 
SS) and Hand. A one-way RM ANOVA with factor Stop Trial Type (GS, SG, SS) tested for 244 
differences in SSRT. 245 
The second hypothesis was examined in the LICI protocol. A one-way RM ANOVA 246 
with 5 Preceding Trial Type (Go Only, GG, GS, SG and SS) was used to analyse CS MEP 247 
amplitude and %INH. Linear regression analyses were performed to examine correlations 248 
between each of %INH and CS MEP amplitude with LTs of the same trial. To assess the 249 
relationship between partial trial CME suppression with both inhibition and response delays, 250 
linear regression analyses were performed investigating correlations between GS trial MEP 251 
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amplitude 175 ms after the stop cue and each of average LICI across trials and GS lift times. 252 
To explore the effects of CME and LICI on lift times linear regression analyses were 253 
performed to assess the correlations of ∆%INH with LTAs and ∆CS MEP amplitude with 254 
LTAs. A paired t-test was used to examine the difference between left hand LTs in stimulated 255 
(following GG trials) and unstimulated GG trials. 256 
Statistical significance was determined by α = 0.05. Post hoc comparisons were 257 
performed using t-tests. Normality was assessed prior to ANOVA using the Shapiro-Wilk 258 
test. Non-spherical data were reported using Greenhouse-Geisser corrected P values. Values 259 
are reported as mean ± standard error.   260 
Results 261 
MEP amplitudes and LICI 262 
For normalized MEP amplitudes of GG and GS trials in the CME protocol (Figure 263 
2A) there was a main effect of Time (F5,75 = 23.8, P < 0.001), but not Trial Type (F1,15 = 0.79, 264 
P = 0.387) or Trial Type × Time interaction (F5,75 = 1.59, P = 0.211). During GG trials, there 265 
was a main effect of Time (F6,90 = 26.6, P < 0.001) where MEP amplitudes at -175, -150, -266 
125 and -100 ms were greater than baseline at -250 ms (all P < 0.008). During GS trials, there 267 
was a main effect of Time (F5,75 = 8.7, P < 0.001) where MEP amplitudes at -100, (t15 = 3.9, 268 
P = 0.001)  and -25 ms (t15 = 4.2, P < 0.001) were greater than baseline at -150 ms, whereas -269 
75 ms (t15 = 1.1, P = 0.289) and -50 ms (t15 = 1.7, P = 0.096) were not.  Additionally, MEP 270 
amplitude at -75 ms was less than -100 ms (t15 = 2.3, P = 0.035), indicative of non-selective 271 
braking 175 ms after the stop signal. For Stop trials (Figure 2B; n = 9), there was no main 272 
effect of Trial Type (F2,16 = 0.78, P = 0.426) or Time (F1,8 = 32.5, P = 0.152) and no Trial 273 
Type × Time interaction (F2,16 = 0.61, P = 0.555). In summary, left FDI MEP amplitudes 274 
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demonstrated suppression 175 ms after a stop signal even when the left side was not cued to 275 
stop (GS trials).  276 
Figure 3 shows averaged left FDI EMG and MEP amplitudes from an individual 277 
participant in the LICI protocol during the Go Only block (Figure 3A) and GS trials in the 278 
Stop task (Figure 3B). For LICI, there was a main effect of Trial Type (F4,48 = 6.5, P = 279 
0.018). Post hoc comparisons revealed that %INH was less during blocks containing only Go 280 
trials (53 ± 6 %) compared with all trial types once Stop trials were introduced (all > 70 %; P 281 
< 0.025) (Figure 4A).  282 
There was a positive correlation between %INH at the start of GS trials and the 283 
resulting LT (r = 0.660, P = 0.014; Figure 4B) such that greater %INH was associated with 284 
longer LTs of the left hand during GS trials. There was no correlation for GG trials (r = 285 
0.032, P = 0.917). There was no correlation between ∆%INH on a GS trial and the LTA on 286 
the subsequent GG trial (r = 0.081, P = 0.792).  287 
For CS MEP amplitude there was a main effect of Trial Type (F4,48 = 3.9, P = 0.034) 288 
(Figure 5). Post hoc comparisons revealed that CS MEP amplitudes were greater following 289 
Go trials in the Stop task (2.3 ± 0.3 mV) than during the Go Only block (1.9 ± 0.3 mV; t12 = 290 
2.4, P = 0.034). Therefore, responding in the context of the Stop task increased CME. 291 
Furthermore, CS MEP amplitudes after GS trials (2.4 ± 0.4 mV) were larger than after SG, 292 
SS and Go Only trials (all < 2.2 ± 0.3 mV; P < 0.047). This indicates that the re-initiation of 293 
movement on a Partial trial increased contralateral M1 excitability which persisted to the start 294 
of the subsequent trial. 295 
For GS trials, there was an association between MEP amplitude 175 ms post stop cue 296 
and LTs (r = -0.544) as well as with LICI (r = -0.504). However, both correlations failed to 297 
reach statistical significance (LTs, P = 0.054; LICI, P = 0.079). There was no correlation 298 
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between CS MEP amplitude at the start of a GG or GS trial and the resulting LT (both r < 299 
0.178, P > 0.560). Likewise, there was no correlation between the ∆CS MEP amplitude on a 300 
GS trial and the LTA on the subsequent Go trial (r = 0.019, P = 0.951).  301 
In the CME protocol, TMT = 38 ± 2% MSO and stimulation intensity = 39 ± 2% 302 
MSO (104 ± 2% TMT). In the LICI protocol, TMT = 43 ± 2% MSO, CS and TS = 56 ± 3% 303 
MSO (129 ± 3 % TMT). The number of trials excluded for rmsEMG > 10 µV was 28 ± 4 % 304 
in the CME and 9 ± 2% in the LICI protocol. In the CME protocol under the GS condition, 7 305 
out of 96 values for MEP amplitude were missing due to pre-trigger EMG and replaced 306 
according to the method described. 307 
Lift times and asynchronies 308 
The task was performed successfully as evident in LTs that were close to the target 309 
(Table 1), and as noted previously for this task (Coxon et al. 2007; 2009; Coxon et al. 2012; 310 
MacDonald et al. 2014; MacDonald et al. 2012). For LTs in the CME protocol, there was a 311 
main effect of Trial Type (F1,15 = 100.0, P < 0.001). No main effect of Hand (F1,15 = 0.7, P = 312 
0.409) or Trial Type × Hand interaction (F1,15 = 0.0, P = 0.887) existed. For the LICI 313 
protocol, there was a main effect of Trial Type (F1,12 = 111.6, P < 0.001). There was a main 314 
effect of Hand (F1,12 = 31.9, P < 0.001) with right LTs (35 ± 4 ms) faster than left (47 ± 4 315 
ms). There was also a Trial Type × Hand interaction (F1,12 = 4.9, P = 0.048), which likely 316 
arose from a trend for longer left hand delays (61 ± 5 ms) than right hand delays (55 ± 6 317 
ms; t12 = 2.1, P = 0.054) between Partial and Go trials. There was no difference in left LTs 318 
between stimulated (19 ± 3 ms) and unstimulated (21 ± 3 ms; t12 = 1.1, P = 0.294) Go trials.  319 
Lift time asynchronies (LTAs) were analysed from GG trials in the Stop task of the 320 
LICI protocol (Table 1). For the Stop task of the LICI protocol, there was a main effect of 321 
Preceding Trial Type (F3,36 = 16.1, P < 0.001) such that LTAs decreased after Partial GS 322 
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compared with after GG trials (t12 = 3.9, P = 0.002). In contrast, LTAs increased after Partial 323 
SG compared with after GG trials (t12 = 4.9, P < 0.001). LTAs were not different after SS 324 
trials compared with after GG trials (t12 = 0.3, P = 0.769). Figure 6 shows the LTs of GG 325 
trials in the Stop task used for LTAs in the LICI protocol. Interestingly, LT on either side was 326 
faster on a subsequent GG trial if that side had previously responded on a Partial trial. There 327 
was a main effect of Preceding Trial Type (F3,36 = 5.6, P = 0.003) and Hand (F1,12 = 35.6, P < 328 
0.001). There was also a Preceding Trial Type × Hand interaction (F3,36 = 15.4, P < 0.001). 329 
Left LTs were faster after GS trials compared with after GG (t12 = 4.6, P = 0.001) and SS 330 
trials (t12 = 2.9, P = 0.014) which did not differ from each other (t12 = 1.0, P = 0.329). 331 
Similarly, right LTs after SG trials were faster compared with after GG (t12 = 5.3, P < 0.001) 332 
and SS trials (t12 = 3.1, P = 0.009) which did not differ from each other (t12 = 0.7, P = 0.500). 333 
For the left hand, LTs were faster if the hand had previously stopped on a Partial trial, 334 
although to a lesser extent than if it had responded (t12 = 4.6, P = 0.001). For the right hand, 335 
LTs were faster after responding versus stopping on a Partial trial (t12 = 3.4, P = 0.005). 336 
Stop signal reaction times and stopping success  337 
Average success on Stop trials was as follows: CME protocol: GS: 76 ± 3%, SG: 61 ± 338 
6%, SS: 58 ± 4%. LICI protocol: GS: 83 ± 3%, SG: 82 ± 3%, SS: 65 ± 3%. In both protocols, 339 
average SSRT showed a main effect of Stop Trial Type (CME: F2,30 = 57.3, P < 0.001, LICI: 340 
F2,24 = 55.5, P < 0.001). SSRT was shorter for SS (CME: 209 ± 3 ms, LICI: 201 ± 2 ms) than 341 
GS (CME: 245 ± 4 ms; t15 = 11.5, P < 0.001, LICI: 236 ± 4 ms; t12 = 9.3, P < 0.001) and SG 342 
trials (CME: 256 ± 4 ms; t15 = 8.6, P < 0.001, LICI: 236 ± 4 ms; t12 = 8.1, P < 0.001). Partial 343 
trial types did not differ from each other in the LICI protocol (t12 = 0.1, P = 0.956), whereas 344 
GS SSRT was shorter than SG in the CME protocol (t15 = 2.3, P = 0.038). 345 
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Discussion 346 
This study provides novel insights into the non-selective suppression of motor output 347 
in the context of reactive response inhibition. As expected, responses were delayed on Partial 348 
trials and temporal modulation of CME for partial response cancellation was consistent with 349 
the anticipation, suppression, and subsequent re-initiation of movement. Furthermore, CME 350 
suppression was evident when one or both hands were required to stop. CME at trial onset 351 
reflected the sum of inhibitory and facilitatory processes required to successfully perform the 352 
previous trial. Changes to LTAs after Partial trials were driven by speeding up of LTs of the 353 
hand that had previously responded. The magnitude of LICI at trial onset was positively 354 
associated with the extent of the delay during GS trials. Interestingly, LICI increased when 355 
Stop trials were introduced compared with a block of trials in which stopping was not a 356 
possibility. These results may indicate that LICI is a proactive mechanism capable of 357 
influencing the interference effect during partial cancellation performed in a reactive context.  358 
Response delays and CME modulation during Stop trials indicated non-selective 359 
suppression. As observed previously, LTs in Partial trials were delayed relative to Go trials 360 
(Coxon et al. 2007; 2009; Coxon et al. 2012; MacDonald et al. 2014; MacDonald et al. 2012). 361 
These substantial delays were observed despite participants achieving relatively high success 362 
rates on Partial trials, especially in the LICI protocol (> 80%). It is important to note that 363 
response delays were not eliminated, or even reduced, when success rate increased as a result 364 
of familiarity with Partial trials; c.f. (Xu et al. 2014). Modulation of MEP amplitude in the 365 
CME protocol supported a model of non-selective suppression during Partial trials. Go trials 366 
displayed a sustained increase in CME from 200 ms before the target. The delay on Partial 367 
trials was a result of an initial facilitation, a dip back to baseline, followed by a secondary 368 
increase in CME. This pattern of CME replicates those of MacDonald et al. (2014). At 369 
equivalent times relative to the stop signal, MEP amplitude did not differ between the three 370 
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types of Stop trials. This finding is consistent with functional magnetic resonance imaging 371 
studies showing a similar pattern of neural activation between the three Stop trial types 372 
(Coxon et al. 2016; Coxon et al. 2009; Coxon et al. 2012). Conversely, functional imaging 373 
results from Majid et al. (2013) suggest a distinct role of the selective indirect basal ganglia 374 
pathway during partial stopping. Activation of the indirect pathway should have no effect on 375 
MEP amplitude in the responding finger during Partial trials. However, all trials in their study 376 
were preceded by a warning cue about stopping requirements. The neural activation in 377 
response may differ if the cue is unexpected. The present study adds weight to the model of 378 
non-selective response inhibition following an unexpected stop cue.  379 
The present study also provides insight into the modulation of intracortical inhibition 380 
during response inhibition. Compared with Go Only blocks, LICI increased when Stop trials 381 
were introduced. The amount of LICI was comparable between Go and Stop trials suggesting 382 
that LICI is not specifically associated with stopping. Previous results using paired-pulse 383 
TMS indicated that increased SICI did not coincide with CME suppression in the responding 384 
effector during partial response inhibition conditions (MacDonald et al. 2014). Together, 385 
these findings indicate that GABAergic circuits within M1 are not primarily responsible for 386 
non-selective suppression during reactive response inhibition. Why then, did LICI increase 387 
during response inhibition trials? It is likely that increased LICI reflects the proactive 388 
modulation of tonic inhibitory circuits as a result of expecting to occasionally stop one or 389 
both hands. Studies have demonstrated that CME is modulated as a result of foreknowledge 390 
about an ensuing response. When response execution is forewarned, SICI and LICI are 391 
decreased in the foreperiod for the muscles cued to respond (Sinclair and Hammond 2008) 392 
while CME is simultaneously reduced, most likely to prevent a premature response 393 
(Davranche et al. 2007; Duque and Ivry 2009). When response prevention is forewarned, 394 
CME is similarly reduced during the foreperiod (Cai et al. 2011), acting as a mark of 395 
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advanced inhibitory control. Prior to this study, there had been no examination of ICI 396 
modulation as a result of the knowledge that a prepared response may need to be prevented. 397 
LICI increased during the foreperiod (trial onset) with the foreknowledge that stopping was a 398 
possibility. Therefore, proactive inhibitory control is at least in part, mediated by changes in 399 
LICI. 400 
The implications of proactively increasing LICI for reactive response inhibition can 401 
be understood within the framework of an activation threshold model (e.g., MacDonald et al. 402 
2014). Tonic levels of inhibition mediate premature response prevention (Duque et al. 2010; 403 
Jaffard et al. 2008) requiring a facilitatory process in order to initiate movement. In the 404 
present study, a concurrent increase in LICI and CME observed on Go trials when Stop trials 405 
were introduced provide candidate mechanisms. The increased CME (facilitation) counteracts 406 
the rise in tonic inhibition and Go trial LTs are thereby maintained on target. However on GS 407 
trials, LTs were markedly delayed. In response to the stop signal, a reactive inhibitory input is 408 
superimposed onto the tonic resting level, raising the threshold for responding (activation 409 
threshold) and effectively cancelling all movement. The trend in the association between 410 
greater CME suppression and greater non-selective inhibition (LICI) on GS trials in the 411 
current study supports such a model. The initial facilitatory process is inadequate to surpass 412 
the activation threshold and a second phase of facilitation must be added, resulting in the 413 
response delay (MacDonald et al. 2014). It is worth noting that longer GS response delays 414 
were associated with higher levels of LICI, supporting the idea that a second phase of 415 
facilitation is required to overcome the tonic resting level. The trend between longer response 416 
delays and CME suppression for GS trials is in agreement with such a second phase of 417 
facilitation. It is interesting that the association between MEP amplitude and response delay 418 
was not stronger for CME evaluated closer in time to the response than LICI measured at trial 419 
onset. A likely explanation is that MEP amplitude reflects the net excitatory and inhibitory 420 
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inputs whereas LICI provides a measure of inhibition only. How LICI is modulated within 421 
the proactive response inhibition network remains unclear (Majid et al. 2013; Van Belle et al. 422 
2014). The present study supports the idea that proactive and reactive control mechanisms are 423 
not independent but rather, reactive stopping depends on ongoing proactive control (Dunovan 424 
et al. 2015).  425 
The within trial processes outlined above have neurophysiological and behavioural 426 
consequences for the subsequent trial. Left hand LT on a Go trial was quicker if preceded by 427 
a GS compared with a Go trial. At the same time, CS MEP amplitude was increased after GS 428 
trials compared with other Stop trial types. Therefore, it may be that the second phase of 429 
facilitation required to respond on GS trials has a carry-on effect which is evident on the next 430 
trial. The second phase of facilitation on SG trials also explains the speeding up of the right 431 
hand on a subsequent Go trial. Interestingly, the hand that stops on a Partial trial also speeds 432 
up to some degree on the subsequent Go trial. We suspect that Partial trials require 433 
“uncoupling” of the two effectors involved in the default Go response, in order to selectively 434 
initiate a unimanual response (MacDonald et al. 2012). Some residual effect of uncoupling is 435 
still present on the subsequent Go trial as is evident by the heightened LTAs after Partial 436 
trials. The presence of (weaker) coupling suggests that the required second phase of 437 
facilitation for the unimanual response on the Partial trial will affect the entire bimanual 438 
response on the following trial. In other words, the hand that stops on a Partial trial to some 439 
extent “comes along for the ride” on a subsequent Go trial. The fact that this dependence is 440 
seen more strongly in left hand LTs aligns with the idea that the nondominant hand is more 441 
stringently coupled to the dominant than vice versa (Byblow et al. 2000; Carson 1993). 442 
Therefore, the after-effects of Partial trials on corticomotor excitability and performance 443 
likely result from the second phase of facilitation, rather than any lingering effects of 444 
inhibition. 445 
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A potential limitation of the present study was the timing of the LICI measurement. 446 
At a cellular level, postsynaptic hyperpolarization mediated by GABAB receptors has been 447 
observed up to 500 ms (Lacaille 1991; Otis et al. 1993). However, it is not feasible to record 448 
LICI with the required stimulus intensities within the time window between CME 449 
suppression and LT without disrupting task performance. Furthermore, it is also difficult to 450 
maintain a comparable level of CME or interpret LICI with a constant test stimulus during or 451 
immediately following trials in a task where there is dynamic modulation of CME. However, 452 
if LICI is responsible for non-selective suppression on Stop trials and the resulting LTAs on 453 
the subsequent trials, one would expect LICI to still be modulated at the time we applied 454 
TMS (i.e. at the onset of trials where LTAs are present). Stimulation at this time is unlikely to 455 
affect task performance (Leocani et al. 2000) with CME variability reduced compared with 456 
times closer to the target (Coxon et al. 2006). However CS MEP amplitude varied following 457 
different trial types. The strength of the CS influences the amount of LICI, with a higher CS 458 
intensity resulting in reduced LICI (Sanger et al. 2001). This has the potential to complicate 459 
the comparison of LICI across and between trials. Nonetheless, it is important to note that the 460 
mean CS MEP amplitude was between 1.9 and 2.4 mV (~130 % of TMT), where similar 461 
amounts of LICI are reported (Opie and Semmler 2014). Furthermore, CS MEP amplitude 462 
did not correlate with GS trial LTs. Thus it is unlikely that CS MEP amplitude could solely 463 
account for the observed pattern of LICI. It is possible that reduced LICI in Go Only blocks 464 
may reflect, in part, an order effect. Go Only trials were always presented first in the LICI 465 
protocol. However, an order effect seems unlikely given that all participants had completed 466 
the CME protocol prior to the LICI protocol, and stop trials were presented throughout the 467 
entire CME protocol.  468 
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In summary, this study provides novel insight into the role of LICI during movement 469 
cancellation. LICI is a proactive mechanism capable of influencing the interference effect 470 
during partial cancellation performed in a reactive context.  471 
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Figure Captions 602 
Figure 1. Bimanual anticipatory response inhibition task. A. Each trial began with the target 603 
line (horizontal black bar) displayed and trial type ambiguous. Go trials (GG) were deemed 604 
successful if both ascending indicators were stopped within 30 ms of the target line (800 ms 605 
into the trial) by lifting the left and right index fingers from switches. To indicate "Success" 606 
the target line turned green. B. Partial trial (GS = Go-Left Stop-Right): the right indicator 607 
automatically stops 550 ms into the trial. This trial type requires the right switch to remain 608 
depressed while the left switch must be released as the rising indicator reaches the target line.  609 
The target line turned red if the indicator stopped greater than 30 ms of the target line or the 610 
hand response was not correctly inhibited (“Miss”). C. Stop-Both trial (SS): Both indicators 611 
stop automatically 600 ms into the trial and a successful trial is achieved when both switches 612 
remain depressed. D. Transcranial magnetic stimulation over the right motor cortex. Motor 613 
evoked potentials (MEPs) were recorded from the first dorsal interosseous (FDI) muscle 614 
during task performance.  615 
 616 
Figure 2. Modulation of left first dorsal interosseous normalized motor evoked potential 617 
(MEP) amplitude during the corticomotor excitability protocol. A. MEP amplitudes before 618 
the target (0 ms) during GG (unfilled circles) and GS (shaded squares) trials (n = 16). Filled 619 
symbols represent values significantly different (P < 0.05) to baseline (GG: -250 ms, GS: -620 
150 ms). Note the dip in corticomotor excitability on GS trials at -75 ms. B. MEP amplitudes 621 
after the stop signal. Bars indicate group means (n = 9). Data correspond to -75 and -50 ms 622 
relative to lift time from Panel A. Note that MEP amplitudes were suppressed 175 ms after 623 
the stop signal regardless of Stop trial type. Error bars indicate 1 SE. * P < 0.05. GG = Go 624 
trial, GS = Go-Left Stop-Right, SG = Stop-Left Go-Right, SS = Stop-Both. 625 
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Figure 3.  Representative left first dorsal interosseous electromyography from a single 626 
participant in the long-interval intracortical inhibition protocol. Vertical dashed line 627 
represents target (800 ms into the trial) and arrows represent average lift time (LT). A. Go 628 
Only block. % inhibition = 48 %, LT = 786 ms, CS motor evoked potential (MEP) amplitude 629 
= 2.2 mV. B. Successful GS trials. % inhibition = 72 %, LT = 868 ms, CS MEP amplitude = 630 
2.2 mV. CS = conditioning stimulus, TS = test stimulus. 631 
Figure 4. Group averages (n = 13) for measures of long-interval intracortical inhibition 632 
(LICI) at trial onset. A. Percent inhibition relative to the previous trial. B. Linear regression 633 
between % LICI and lift times within GG (unfilled circles) and successful GS trials (filled 634 
squares). Error bars indicate 1 SE. * P < 0.05. Go Only = block with only Go trials possible, 635 
GG = Go trial in the context of the response inhibition task, GS = Go-Left Stop-Right, SG = 636 
Stop-Left Go-Right, SS = Stop-Both. 637 
Figure 5. Corticomotor excitability at trial onset. Bars are group averages (n = 13) of the 638 
conditioning stimulus (CS) motor evoked potential (MEP) amplitude at trial onset relative to 639 
previous trial type. Only data following successful Stop trials were included in the analysis. 640 
Error bars indicate 1 SE. * P < 0.05. Go Only = block with only Go trials possible, GG = Go 641 
trial in the context of the response inhibition task, GS = Go-Left Stop-Right, SG = Stop-Left 642 
Go-Right, SS = Stop-Both. 643 
Figure 6. Lift times on Go trials following different trial types. Bars indicate group means (n 644 
= 13). Black horizontal lines denote when the hand had previously stopped on a Partial trial. 645 
Note that for both hands lift times were faster on a subsequent Go trial if the hand had 646 
previously responded on a Partial trial. Error bars indicate 1 SE. * P < 0.05, ** P < 0.001.  647 
 648 
 649 
Tables 650 
Table 1. Summary of behavioural data from both protocols. 651 
 LTs 
 Go (L) Go (R) Go Avg Partial GS Partial SG Partial Avg 
CME protocol (ms) 16±3 13±2 14±2 70±8 66±7 68±6* 
LICI protocol (ms) 17±2 7±2 12±2 78±6 62±6 70±6* 
LICI protocol Preceding trial type 
 Go Partial GS Partial SG Stop Both 
LTA (ms) 10±2 3±2† 14±2† 9±1 
Values are mean±SE lift times (LTs) displayed relative to the target (800 ms). Lift time asynchronies (LTAs) are determined as left LT – right 652 
LT in Go trials. GS = Go-Left Stop-Right, SG = Stop-Left Go-Right. * P < 0.001 compared with Go Avg, † P < 0.01 compared with Go trials.  653 
 654 
 655 






